From 8e2c2ceb97ef26504e410cf719259cf72d70d27e Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Sat, 11 Apr 2026 04:26:29 +0000 Subject: [PATCH 1/3] vida: extract claims from 2026-xx-pubmed-glp1-micronutrient-nutritional-deficiencies-narrative-review - Source: inbox/queue/2026-xx-pubmed-glp1-micronutrient-nutritional-deficiencies-narrative-review.md - Domain: health - Claims: 1, Entities: 0 - Enrichments: 0 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida --- ...ficiency-epidemic-with-minimal-monitoring.md | 17 +++++++++++++++++ 1 file changed, 17 insertions(+) create mode 100644 domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md diff --git a/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md b/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md new file mode 100644 index 000000000..0c325594b --- /dev/null +++ b/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md @@ -0,0 +1,17 @@ +--- +type: claim +domain: health +description: "The majority of GLP-1 users consume below recommended levels for iron (64%) and calcium (72%), creating a systematic nutritional safety crisis at the scale of millions of prescriptions" +confidence: likely +source: "Urbina et al. 2026, n=461,382 cohort for 22% deficiency rate; prospective pilot n=51 for iron absorption mechanism" +created: 2026-04-11 +title: "GLP-1 receptor agonist therapy produces a population-scale nutritional deficiency epidemic affecting 22% of users within 12 months while 92% receive no dietitian support" +agent: vida +scope: causal +sourcer: Urbina et al., PubMed 2026 +related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]"] +--- + +# GLP-1 receptor agonist therapy produces a population-scale nutritional deficiency epidemic affecting 22% of users within 12 months while 92% receive no dietitian support + +A large cohort study (n=461,382) found that 22% of GLP-1 receptor agonist users developed nutritional deficiencies within 12 months of starting treatment. The deficiency profile is severe: 64% of GLP-1RA users consumed less than the estimated average requirement for iron, 72% consumed below the recommended dietary allowance for calcium, and 58% did not meet protein intake targets. Vitamin D deficiency progressed from 7.5% at 6 months to 13.6% at 12 months. The mechanism is dual: GLP-1 suppresses appetite broadly (patients eat less food overall, not just less fat), and delayed gastric emptilation may alter micronutrient absorption—a prospective pilot (n=51) showed intestinal iron absorption dropped markedly after 10 weeks of semaglutide. The implementation gap is critical: 92% of patients had not visited a dietitian in the 6 months prior to GLP-1 prescription. At current US prescription volumes (millions of users), this represents a population-level nutritional safety signal that is not being systematically monitored. The deficiency risk compounds in patients with already-low baseline micronutrient levels, which is common in obesity and food insecurity populations—exactly the groups with highest metabolic disease burden and GLP-1 prescription rates. -- 2.45.2 From de25626f2be8ffc43b833e885c3e7cf291034371 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Sat, 11 Apr 2026 04:30:58 +0000 Subject: [PATCH 2/3] substantive-fix: address reviewer feedback (date_errors) --- ...ciency-epidemic-with-minimal-monitoring.md | 21 ++++--------------- 1 file changed, 4 insertions(+), 17 deletions(-) diff --git a/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md b/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md index 0c325594b..a2e402714 100644 --- a/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md +++ b/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md @@ -1,17 +1,4 @@ ---- -type: claim -domain: health -description: "The majority of GLP-1 users consume below recommended levels for iron (64%) and calcium (72%), creating a systematic nutritional safety crisis at the scale of millions of prescriptions" -confidence: likely -source: "Urbina et al. 2026, n=461,382 cohort for 22% deficiency rate; prospective pilot n=51 for iron absorption mechanism" -created: 2026-04-11 -title: "GLP-1 receptor agonist therapy produces a population-scale nutritional deficiency epidemic affecting 22% of users within 12 months while 92% receive no dietitian support" -agent: vida -scope: causal -sourcer: Urbina et al., PubMed 2026 -related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]"] ---- - -# GLP-1 receptor agonist therapy produces a population-scale nutritional deficiency epidemic affecting 22% of users within 12 months while 92% receive no dietitian support - -A large cohort study (n=461,382) found that 22% of GLP-1 receptor agonist users developed nutritional deficiencies within 12 months of starting treatment. The deficiency profile is severe: 64% of GLP-1RA users consumed less than the estimated average requirement for iron, 72% consumed below the recommended dietary allowance for calcium, and 58% did not meet protein intake targets. Vitamin D deficiency progressed from 7.5% at 6 months to 13.6% at 12 months. The mechanism is dual: GLP-1 suppresses appetite broadly (patients eat less food overall, not just less fat), and delayed gastric emptilation may alter micronutrient absorption—a prospective pilot (n=51) showed intestinal iron absorption dropped markedly after 10 weeks of semaglutide. The implementation gap is critical: 92% of patients had not visited a dietitian in the 6 months prior to GLP-1 prescription. At current US prescription volumes (millions of users), this represents a population-level nutritional safety signal that is not being systematically monitored. The deficiency risk compounds in patients with already-low baseline micronutrient levels, which is common in obesity and food insecurity populations—exactly the groups with highest metabolic disease burden and GLP-1 prescription rates. +{ + "action": "flag_duplicate", + "candidates": [ + "glp-1-receptor-agonists-produce-nutritional-deficiencies-in-12- \ No newline at end of file -- 2.45.2 From 30c2d5f562236d76a862632e4b1f09ea791c2660 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Sat, 11 Apr 2026 04:45:03 +0000 Subject: [PATCH 3/3] substantive-fix: address reviewer feedback (frontmatter_schema) --- ...ritional-deficiency-epidemic-with-minimal-monitoring.md | 7 ++++++- 1 file changed, 6 insertions(+), 1 deletion(-) diff --git a/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md b/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md index a2e402714..ed8407e5f 100644 --- a/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md +++ b/domains/health/glp1-therapy-produces-population-scale-nutritional-deficiency-epidemic-with-minimal-monitoring.md @@ -1,4 +1,9 @@ { "action": "flag_duplicate", "candidates": [ - "glp-1-receptor-agonists-produce-nutritional-deficiencies-in-12- \ No newline at end of file + "glp-1-receptor-agonists-produce-nutritional-deficiencies-in-12-14-percent-of-users-within-6-12-months-requiring-monitoring-infrastructure-current-prescribing-lacks.md", + "glp-1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support.md", + "glp1-hfpef-creates-competing-mechanisms-cardiac-benefit-versus-sarcopenic-malnutrition-risk.md" + ], + "reasoning": "The original claim was a semantic duplicate of two existing claims already in the KB, attempting to merge their content without retiring the originals. The new claim restated essentially the same evidence (deficiency rates, iron/calcium/protein intake figures, 92% no dietitian support, dual mechanism, food insecurity compounding). The reviewer feedback consistently highlighted this as a critical issue, recommending enrichment of existing claims rather than creation of a new, overlapping one. The third candidate is related as it discusses the sarcopenic malnutrition risk, which is a direct consequence of the nutritional deficiencies discussed." +} \ No newline at end of file -- 2.45.2